Chinese Antibody Society has invited 15 prestigious speakers and panelists in biopharma industry and academia. They include one member of National Academy of Sciences and a member of National Academy of Engineering in the US. The conference will feature two panel discussions. The first one with a theme of bispecific antibodies will be hosted by Dr. Chengbin Wu, CEO of EpimAb Biotherapeutics. The second one with a focus on CMC will be hosted by Dr. Steven Lee, CEO and Founder of BioGENEXIUS. More speakers and panelists will be invited to share their insights on R&D, manufacture, clinical trial and commercialization of next generation therapeutic antibodies.